Cargando…
Ischemia and reperfusion injury combined with cisplatin induces immunogenic cell death in lung cancer cells
A first-line chemotherapeutic drug for non-small cell lung cancer (NSCLC), cisplatin (CDDP), fails to induce immunogenic cell death (ICD) because it fails to induce calreticulin (CRT) exposure on the cell surface. We investigated the potential of ischemia and reperfusion injury (I/R) combined with C...
Autores principales: | Zhang, Shuai, Li, Yumei, Liu, Shuqing, Ma, Pei, Guo, Mengfei, Zhou, E., Duan, Limin, Fan, Jinshuo, Liao, Tingting, Tan, Qi, Wang, Xuan, Wu, Feng, Jin, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440929/ https://www.ncbi.nlm.nih.gov/pubmed/36057637 http://dx.doi.org/10.1038/s41419-022-05176-y |
Ejemplares similares
-
Value of (18)F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
por: Lv, Zhilei, et al.
Publicado: (2017) -
PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons
por: Yan, Wei-Tao, et al.
Publicado: (2022) -
Mechanism and Therapies of Oxidative Stress-Mediated Cell Death in Ischemia Reperfusion Injury
por: Li, Haobo, et al.
Publicado: (2018) -
Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis
por: Fan, Jinshuo, et al.
Publicado: (2018) -
A Possible Mechanism of Renal Cell Death after Ischemia/reperfusion
por: Price, Peter M., et al.
Publicado: (2012)